This article is more than 5 years old. Information may no longer be current.

STAAR reports net loss for second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported $15.9 million in total revenue for the second quarter, with a net loss of $491,000, according to a company press release.

STAAR reported net income of $861,000 in the same quarter last year, the release said.

“Our nine consecutive quarters of year-over-year growth was interrupted during the second quarter due to the unusual combination of three sales limiting dynamics,” Barry Caldwell, president and CEO of STAAR, said in the release. “The shortfall to revenue expectations was about $2 million.”

Revenue shortfalls were attributed to a flattening of refractive procedures in China, the timing of a stocking order from STAAR’s Korean distributor and a planned transition to a direct-selling model for the Visian ICL in Spain, Caldwell said.

Sales of the Visian ICL grew 4% to $8.6 million, while IOL sales decreased 4% to $6.8 million, the release said.